Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295087 · ClinicalTrials.gov registry record
X-Chromosome Inactivation Status and Premature Ovarian Failure
A clinical trial of Premature Ovarian Failure, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 13
- Enrollment target
- 1
- Study location
NCT00295087 is a study of Premature Ovarian Failure that has completed, run by University of Pittsburgh. The registered enrollment target is 13 participants, below the 86-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00295087, a study of Premature Ovarian Failure, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.
Conditions Studied
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2005-11 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00295087
The ClinicalTrials.gov registry entry for NCT00295087 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 3 other Premature Ovarian Failure trials with a reported enrollment target (85% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Premature Ovarian Failure appearing as the primary indexed condition, and to 0 interventions.
NCT00295087 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00295087 about?
NCT00295087 is a clinical study titled "X-Chromosome Inactivation Status and Premature Ovarian Failure". Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.
What is the current status of trial NCT00295087?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2005-11. Estimated completion is 2009-10.
What conditions does trial NCT00295087 study?
This clinical trial studies the following conditions: Premature Ovarian Failure.
Who is sponsoring clinical trial NCT00295087?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00295087 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Ovarian Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.